This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Mass screening for open spina bifida needs careful consideration
Recent British experience with the use of α-fetoprotein (α-fp) levels in amniotic fluid and maternal blood to detect neural tube defects (NTDs) has confronted Americans with some difficult decisions. British studies have established that elevated α-fp levels in amniotic fluid are diagnostic for anencephaly and open spina bifida and that measurement of α-fp levels in the serum of pregnant women can also detect a high proportion of these fetal abnormalities. (Closed spina bifida is only sometimes associated with elevated α-fp levels.) However, the decision of whether to use amniocentesis in all high-risk pregnancies, to institute maternal serum screening for NTDs, or to do neither depends only partly on the sensitivity of the tests. Important nonmedical factors include financial costs and benefits of such programs, practical difficulties in implementing them, psychological benefits to parents, and the public's cooperation with the programs.
Medical News. JAMA. 1977;238(14):1441–1456. doi:10.1001/jama.1977.03280150011001
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: